IS:THYROCARE Thyrocare Technologies Limited

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through Diagnostic Testing Services, Imaging Services, and Others segments. The company conducts medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radio pharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. As of September 1, 2021, Thyrocare Technologies Limited operates as a subsidiary of Docon Technologies Private Limited.

963.80 INR
As of 01/21/2022


Security Information
Category1:  Global Equity
Category2:  Comon stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  
Index country:  India
Country of incorporation:  India
IPO date:  05/09/2016
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   50,988,199,936 INR
Current dividend yield:   2.51%
Sedol:      

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy